FDA inspection
The University of Texas MD Anderson Cancer Center IRB: FDA inspection ending Mar 12, 2019
FDA inspection 1085580 · No Action Indicated (NAI) · Houston, TX
Key facts
| Inspection ID | 1085580 |
|---|---|
| Firm | The University of Texas MD Anderson Cancer Center IRB |
| FEI number | 1626261 |
| Address | 1515 Holcombe Boulevard, Office Of Human Subjects Protection (Ohsp), Unit 1637 |
| City | Houston |
| State | TX |
| ZIP | 77030 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Mar 12, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data